• Korea Fixed-Income Investment Management disclosed a new 6.22% stake in EnBio, totaling 720,461 shares equivalent.
• Position was built via subscription to convertible bonds, with the disclosure dated Oct. 12, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. EnBio Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261013000027), on October 13, 2026, and is solely responsible for the information contained therein.